Some opposition lawmakers are questioning the government’s continued preference for Sinovac Biotech’s coronavirus vaccine, even after late-stage clinical trials in Brazil showed that its efficacy rate only stands at 50%.
Full Post on Source: Gov’t hit over preference for Sinovac’s ‘pasang-awa’ vaccine
